Skip to main content

Published locations for TNF Inhibitors May Reduce Cardiovascular Risks in Psoriasis Patients: Report From the AAD Meeting

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. TNF Inhibitors May Reduce Cardiovascular Risks in Psoriasis Patients: Report From the AAD Meeting

User login

  • Reset your password
  • /content/tnf-inhibitors-may-reduce-cardiovascular-risks-psoriasis-patients-report-aad-meeting
  • /cutis/article/100575/psoriasis/tnf-inhibitors-may-reduce-cardiovascular-risks-psoriasis-patients
  • /dermatology/article/100575/psoriasis/tnf-inhibitors-may-reduce-cardiovascular-risks-psoriasis
  • /dermatology/psoriasiscollection/article/100575/psoriasis/tnf-inhibitors-may-reduce-cardiovascular
  • /breast-cancer-icymi/article/100575/psoriasis/tnf-inhibitors-may-reduce-cardiovascular-risks
  • /b-cell-lymphoma-icymi/article/100575/psoriasis/tnf-inhibitors-may-reduce-cardiovascular-risks